159 related articles for article (PubMed ID: 22277800)
41. Genetic polymorphisms in glutathione S-transferases P1 (GSTP1) Ile105Val and prostate cancer risk: a systematic review and meta-analysis.
Cai Q; Wu T; Zhang W; Guo X; Shang Z; Jiang N; Tian J; Niu Y
Tumour Biol; 2013 Dec; 34(6):3913-22. PubMed ID: 23843029
[TBL] [Abstract][Full Text] [Related]
42. Soy isoflavones, CYP1A1, CYP1B1, and COMT polymorphisms, and breast cancer: a case-control study in southwestern China.
Wang Q; Li H; Tao P; Wang YP; Yuan P; Yang CX; Li JY; Yang F; Lee H; Huang Y
DNA Cell Biol; 2011 Aug; 30(8):585-95. PubMed ID: 21438753
[TBL] [Abstract][Full Text] [Related]
43. The association of the CYP1A1 Ile462Val polymorphism with head and neck cancer risk: evidence based on a cumulative meta-analysis.
Wang Y; Yang H; Duan G; Wang H
Onco Targets Ther; 2016; 9():2927-34. PubMed ID: 27274286
[TBL] [Abstract][Full Text] [Related]
44. Association between cytochrome P450 1A1 MspI polymorphism and endometrial cancer risk: a meta-analysis.
Han L; Liu Y; Cao W; Yuan X; Li C
Tumour Biol; 2013 Oct; 34(5):2545-50. PubMed ID: 23918309
[TBL] [Abstract][Full Text] [Related]
45. CYP1A1 MspI polymorphisms and lung cancer risk: an updated meta-analysis involving 20,209 subjects.
Ji YN; Wang Q; Lin XQ; Suo LJ
Cytokine; 2012 Aug; 59(2):324-34. PubMed ID: 22579698
[TBL] [Abstract][Full Text] [Related]
46. Susceptibility of lung cancer with polymorphisms of CYP1A1, GSTM1, GSTM3, GSTT1 and GSTP1 genotypes in the population of Inner Mongolia region.
Jiang XY; Chang FH; Bai TY; Lv XL; Wang MJ
Asian Pac J Cancer Prev; 2014; 15(13):5207-14. PubMed ID: 25040976
[TBL] [Abstract][Full Text] [Related]
47. Effect of genetic predisposition on the risk of gallbladder cancer in Hungary.
Kimura A; Tsuchiya Y; Lang I; Zoltan S; Nakadaira H; Ajioka Y; Kiyohara C; Oyama M; Nakamura K
Asian Pac J Cancer Prev; 2008; 9(3):391-6. PubMed ID: 18990008
[TBL] [Abstract][Full Text] [Related]
48. Phase I/II enzyme gene polymorphisms and esophageal cancer risk: a meta-analysis of the literature.
Yang CX; Matsuo K; Wang ZM; Tajima K
World J Gastroenterol; 2005 May; 11(17):2531-8. PubMed ID: 15849806
[TBL] [Abstract][Full Text] [Related]
49. Lack of association between HER2 codon 655 polymorphism and breast cancer susceptibility: meta-analysis of 22 studies involving 19,341 subjects.
Ma Y; Yang J; Zhang P; Liu Z; Yang Z; Qin H
Breast Cancer Res Treat; 2011 Jan; 125(1):237-41. PubMed ID: 20524057
[TBL] [Abstract][Full Text] [Related]
50. CYP1A1 and CYP1B1 polymorphisms and risk of lung cancer among never smokers: a population-based study.
Wenzlaff AS; Cote ML; Bock CH; Land SJ; Santer SK; Schwartz DR; Schwartz AG
Carcinogenesis; 2005 Dec; 26(12):2207-12. PubMed ID: 16051642
[TBL] [Abstract][Full Text] [Related]
51. Cytochrome P450 CYP1A1 MspI polymorphism and lung cancer susceptibility.
Xu X; Kelsey KT; Wiencke JK; Wain JC; Christiani DC
Cancer Epidemiol Biomarkers Prev; 1996 Sep; 5(9):687-92. PubMed ID: 8877059
[TBL] [Abstract][Full Text] [Related]
52. CYP1A1 polymorphism and risk of gynecological malignancy in Japan.
Sugawara T; Nomura E; Sagawa T; Sakuragi N; Fujimoto S
Int J Gynecol Cancer; 2003; 13(6):785-90. PubMed ID: 14675315
[TBL] [Abstract][Full Text] [Related]
53. Association between glutathione S-transferase P1 Ile (105) Val gene polymorphism and chronic obstructive pulmonary disease: A meta-analysis based on seventeen case-control studies.
Yang L; Li X; Tong X; Fan H
Meta Gene; 2015 Dec; 6():59-64. PubMed ID: 26504746
[TBL] [Abstract][Full Text] [Related]
54. CYP1A1 gene polymorphism as a risk factor for cervical intraepithelial neoplasia and invasive cervical cancer.
Taskiran C; Aktas D; Yigit-Celik N; Alikasifoglu M; Yuce K; Tunçbilek E; Ayhan A
Gynecol Oncol; 2006 Jun; 101(3):503-6. PubMed ID: 16403567
[TBL] [Abstract][Full Text] [Related]
55. Quantitative assessment of the association between CYP1A1 A4889G polymorphism and endometrial cancer risk.
Li M; Li YY; Xin XY; Han Y; Wu TT; Wang HB
Tumour Biol; 2013 Dec; 34(6):3675-80. PubMed ID: 23860774
[TBL] [Abstract][Full Text] [Related]
56. Lack of associations of the COMT Val158Met polymorphism with risk of endometrial and ovarian cancer: a pooled analysis of case-control studies.
Liu JX; Luo RC; Li R; Li X; Guo YW; Ding DP; Chen YZ
Asian Pac J Cancer Prev; 2014; 15(15):6181-6. PubMed ID: 25124595
[TBL] [Abstract][Full Text] [Related]
57. Association of CYP1A1, CYP1A2, GSTM1 and NAT2 gene polymorphisms with colorectal cancer and smoking.
Yoshida K; Osawa K; Kasahara M; Miyaishi A; Nakanishi K; Hayamizu S; Osawa Y; Tsutou A; Tabuchi Y; Shimada E; Tanaka K; Yamamoto M; Takahashi J
Asian Pac J Cancer Prev; 2007; 8(3):438-44. PubMed ID: 18159984
[TBL] [Abstract][Full Text] [Related]
58. CYP1A1 MspI polymorphism is associated with prostate cancer susceptibility: evidence from a meta-analysis.
Ding G; Xu W; Liu H; Zhang M; Huang Q; Liao Z
Mol Biol Rep; 2013 May; 40(5):3483-91. PubMed ID: 23475304
[TBL] [Abstract][Full Text] [Related]
59. Polymorphisms of CYP1A1 and GSTM1 and laryngeal cancer risk: evidence-based meta-analyses.
Zhuo WL; Wang Y; Zhuo XL; Zhu B; Zhu Y; Chen ZT
J Cancer Res Clin Oncol; 2009 Aug; 135(8):1081-90. PubMed ID: 19252926
[TBL] [Abstract][Full Text] [Related]
60. CYP1A1 gene polymorphism and risk of endometrial hyperplasia and endometrial carcinoma.
Esinler I; Aktas D; Alikasifoglu M; Tuncbilek E; Ayhan A
Int J Gynecol Cancer; 2006; 16(3):1407-11. PubMed ID: 16803538
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
